Cachexia worsens prognosis in patients with resectable pancreatic cancer

Journal of Gastrointestinal Surgery

Volumn 12, Issue 7, 2008, Pages 1193-1201

  Bachmann, Jeannine ^a   Heiligensetzer, Mathias ^a   Krakowski Roosen, Holger ^b   Büchler, Markus W ^c   Friess, Helmut ^a   Martignoni, Marc E ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cachexia; Nutritional status; Pancreatic cancer; Survival

Indexed keywords

AGED; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER STAGING; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GERMANY; HUMAN; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; NUTRITIONAL SUPPORT; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREAS TUMOR; PATHOLOGY; POSTOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; BODY WEIGHT; CACHEXIA; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; NUTRITIONAL SUPPORT; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 46249115321     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-008-0505-z     Document Type: Article

References (41)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Nakao A, Fujii T, Sugimoto H et al. Oncological problems in pancreatic cancer surgery. World J Gastroenterol 2006;12:4466-4472.
3. Noto M, Miwa K, Kitagawa H et al. Pancreas head carcinoma: frequency of invasion to soft tissue adherent to the superior mesenteric artery. Am J Surg Pathol 2005;29:1056-1061.
4. Schafer M, Mullhaupt B, Clavien PA. Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 2002;236:137-148.
5. Trede M, Richter A, Wendl K. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 2001;81:595-610.
6. Kleeff J, Michalski C, Friess H et al. Pancreatic cancer: from bench to 5-year survival. Pancreas 2006;33:111-118.
7. Kleeff J, Michalski CW, Friess H et al. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. Eur J Surg Oncol 2007;33:817-823.
8. Beger HG, Rau B, Gansauge F et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003;27:1075-1084.
9. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273-279.
10. Imamura M, Doi R, Imaizumi T et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 2004;136:1003-1011.
11. Wagner M, Redaelli C, Lietz M et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 2004;91:586-594.
12. Friess H, Isenmann R, Berberat P et al. [Prognosis in pancreatic carcinoma]. Ther Umsch 1996;53:401-407.
13. Alexakis N, Halloran C, Raraty M et al. Current standards of surgery for pancreatic cancer. Br J Surg 2004;91:1410-1427.
14. Liu SL, Friess H, Kleeff J et al. Surgical approaches for resection of pancreatic cancer: an overview. Hepatobiliary Pancreat Dis Int 2002;1:118-125.
15. Ihse I, Anderson H, Andren S. Total pancreatectomy for cancer of the pancreas: is it appropriate? World J Surg 1996;20:288-293.
16. Karpoff HM, Klimstra DS, Brennan MF et al. Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 2001;136:44-47.
17. Neoptolemos JP, Stocken DD, Friess H et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
18. Davidson W, Ash S, Capra S et al. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 2004;23:239-247.
19. Nelson KA. Modern management of the cancer anorexia-cachexia syndrome. Curr Oncol Rep 2000;2:362-368.
20. Palesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinal cancer. Dig Dis 2003;21:198-213.
21. Ripamonti C. Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7:233-243.
22. Argiles JM, Meijsing SH, Pallares-Trujillo J et al. Cancer cachexia: a therapeutic approach. Med Res Rev 2001;21:83-101.
23. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res 1999;59:4493-4501.
24. Lorite MJ, Smith HJ, Arnold JA et al. Activation of ATP-ubiquitin- dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001;85:297-302.
25. Moses AW, Slater C, Preston T et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 2004;90:996-1002.
26. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2002;2:862-871.
27. Laviano A, Meguid MM, Inui A et al. Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol 2005;2:158-165.
28. Tisdale MJ. Metabolic abnormalities in cachexia and anorexia. Nutrition 2000;16:1013-1014.
29. Ripamonti C. Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7:233-243.
30. Costelli P, Baccino FM. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis. Curr Opin Clin Nutr Metab Care 2003;6:407-412.
31. Bosaeus I, Daneryd P, Svanberg E et al. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 2001;93:380-383.
32. Fearon KC, Barber MD, Falconer JS et al. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 1999;23:584-588.
33. Kobari M, Matsuno S. Staging systems for pancreatic cancer: differences between the Japanese and UICC systems. J Hepatobiliary Pancreat Surg 1998;5:121-127.
34. Pankreas. In Wittekind C, Meyer HJ, Bootz F, eds. TNM Klassifikation Maligner Tumoren. New York: Springer, 2006, pp 83-85.
35. Buchler MW, Friess H, Wagner M et al. Pancreatic fistula after pancreatic head resection. Br J Surg 2000;87:883-889.
36. Friess H, Beger HG, Sulkowski U et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-1273.
37. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005;8:265-269.
38. Hiratsuka S, Watanabe A, Aburatani H et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006;8:1369-1375.
39. Glare P. Clinical predictors of survival in advanced cancer. J Support Oncol 2005;3:331-339.
40. Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313-5327.
41. Dank M. [Tumorus anorexia/cachexia syndrome]. Magy Onkol 2001;45:431-436.